ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Short-acting GLP-1RA Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-22C16072
Home | Market Reports | Health| Pharmacy
Global Short acting GLP 1RA Market Research Report 2023
BUY CHAPTERS

Global Short-acting GLP-1RA Market Research Report 2025

Code: QYRE-Auto-22C16072
Report
June 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Sanofi
Shanghai Benemae Pharmaceutical

Short-acting GLP-1RA Market Size

The global market for Short-acting GLP-1RA was valued at US$ 7133 million in the year 2024 and is projected to reach a revised size of US$ 10870 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Short-acting GLP-1RA Market

Short-acting GLP-1RA Market

Short-acting GLP-1RAs, or short-acting Glucagon-Like Peptide-1 Receptor Agonists, have a relatively shorter half-life, which is advantageous for slowing gastric emptying and, thus, better controlling post-meal blood sugar levels.
Short-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is a class of drugs used to treat type 2 diabetes by mimicking the action of the GLP-1 hormone, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and a sense of fullness. Currently, the market share of short-acting GLP-1RA is relatively small. However, with ongoing innovation and technological advancements in the diabetes treatment field, short-acting GLP-1RA presents potential growth opportunities in the pharmaceutical market. Due to its rapid effects and more flexible administration, short-acting GLP-1RA is attractive for patients in need of more timely and personalized treatment. In the future, as medical technology continues to advance, short-acting GLP-1RA is expected to play a more significant role in diabetes treatment, providing patients with more effective medication choices.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Short-acting GLP-1RA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short-acting GLP-1RA.
The Short-acting GLP-1RA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short-acting GLP-1RA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short-acting GLP-1RA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Short-acting GLP-1RA Market Report

Report Metric Details
Report Name Short-acting GLP-1RA Market
Accounted market size in year US$ 7133 million
Forecasted market size in 2031 US$ 10870 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Exenatide
  • Beinaglutide
  • Lixisenatide
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Sanofi, Shanghai Benemae Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Short-acting GLP-1RA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Short-acting GLP-1RA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Short-acting GLP-1RA Market growing?

Ans: The Short-acting GLP-1RA Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Short-acting GLP-1RA Market size in 2031?

Ans: The Short-acting GLP-1RA Market size in 2031 will be US$ 10870 million.

Who are the main players in the Short-acting GLP-1RA Market report?

Ans: The main players in the Short-acting GLP-1RA Market are AstraZeneca, Sanofi, Shanghai Benemae Pharmaceutical

What are the Application segmentation covered in the Short-acting GLP-1RA Market report?

Ans: The Applications covered in the Short-acting GLP-1RA Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Short-acting GLP-1RA Market report?

Ans: The Types covered in the Short-acting GLP-1RA Market report are Exenatide, Beinaglutide, Lixisenatide

1 Short-acting GLP-1RA Market Overview
1.1 Product Definition
1.2 Short-acting GLP-1RA by Type
1.2.1 Global Short-acting GLP-1RA Market Value Comparison by Type (2024 VS 2031)
1.2.2 Exenatide
1.2.3 Beinaglutide
1.2.4 Lixisenatide
1.3 Short-acting GLP-1RA by Application
1.3.1 Global Short-acting GLP-1RA Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Short-acting GLP-1RA Market Size Estimates and Forecasts
1.4.1 Global Short-acting GLP-1RA Revenue 2020-2031
1.4.2 Global Short-acting GLP-1RA Sales 2020-2031
1.4.3 Global Short-acting GLP-1RA Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Short-acting GLP-1RA Market Competition by Manufacturers
2.1 Global Short-acting GLP-1RA Sales Market Share by Manufacturers (2020-2025)
2.2 Global Short-acting GLP-1RA Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Short-acting GLP-1RA Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Short-acting GLP-1RA, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short-acting GLP-1RA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short-acting GLP-1RA, Product Type & Application
2.7 Global Key Manufacturers of Short-acting GLP-1RA, Date of Enter into This Industry
2.8 Global Short-acting GLP-1RA Market Competitive Situation and Trends
2.8.1 Global Short-acting GLP-1RA Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short-acting GLP-1RA Players Market Share by Revenue
2.8.3 Global Short-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short-acting GLP-1RA Market Scenario by Region
3.1 Global Short-acting GLP-1RA Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Short-acting GLP-1RA Sales by Region: 2020-2031
3.2.1 Global Short-acting GLP-1RA Sales by Region: 2020-2025
3.2.2 Global Short-acting GLP-1RA Sales by Region: 2026-2031
3.3 Global Short-acting GLP-1RA Revenue by Region: 2020-2031
3.3.1 Global Short-acting GLP-1RA Revenue by Region: 2020-2025
3.3.2 Global Short-acting GLP-1RA Revenue by Region: 2026-2031
3.4 North America Short-acting GLP-1RA Market Facts & Figures by Country
3.4.1 North America Short-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Short-acting GLP-1RA Sales by Country (2020-2031)
3.4.3 North America Short-acting GLP-1RA Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Short-acting GLP-1RA Market Facts & Figures by Country
3.5.1 Europe Short-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Short-acting GLP-1RA Sales by Country (2020-2031)
3.5.3 Europe Short-acting GLP-1RA Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short-acting GLP-1RA Market Facts & Figures by Region
3.6.1 Asia Pacific Short-acting GLP-1RA Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Short-acting GLP-1RA Sales by Region (2020-2031)
3.6.3 Asia Pacific Short-acting GLP-1RA Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Short-acting GLP-1RA Market Facts & Figures by Country
3.7.1 Latin America Short-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Short-acting GLP-1RA Sales by Country (2020-2031)
3.7.3 Latin America Short-acting GLP-1RA Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Short-acting GLP-1RA Market Facts & Figures by Country
3.8.1 Middle East and Africa Short-acting GLP-1RA Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Short-acting GLP-1RA Sales by Country (2020-2031)
3.8.3 Middle East and Africa Short-acting GLP-1RA Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short-acting GLP-1RA Sales by Type (2020-2031)
4.1.1 Global Short-acting GLP-1RA Sales by Type (2020-2025)
4.1.2 Global Short-acting GLP-1RA Sales by Type (2026-2031)
4.1.3 Global Short-acting GLP-1RA Sales Market Share by Type (2020-2031)
4.2 Global Short-acting GLP-1RA Revenue by Type (2020-2031)
4.2.1 Global Short-acting GLP-1RA Revenue by Type (2020-2025)
4.2.2 Global Short-acting GLP-1RA Revenue by Type (2026-2031)
4.2.3 Global Short-acting GLP-1RA Revenue Market Share by Type (2020-2031)
4.3 Global Short-acting GLP-1RA Price by Type (2020-2031)
5 Segment by Application
5.1 Global Short-acting GLP-1RA Sales by Application (2020-2031)
5.1.1 Global Short-acting GLP-1RA Sales by Application (2020-2025)
5.1.2 Global Short-acting GLP-1RA Sales by Application (2026-2031)
5.1.3 Global Short-acting GLP-1RA Sales Market Share by Application (2020-2031)
5.2 Global Short-acting GLP-1RA Revenue by Application (2020-2031)
5.2.1 Global Short-acting GLP-1RA Revenue by Application (2020-2025)
5.2.2 Global Short-acting GLP-1RA Revenue by Application (2026-2031)
5.2.3 Global Short-acting GLP-1RA Revenue Market Share by Application (2020-2031)
5.3 Global Short-acting GLP-1RA Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Short-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Short-acting GLP-1RA Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Short-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Short-acting GLP-1RA Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Shanghai Benemae Pharmaceutical
6.3.1 Shanghai Benemae Pharmaceutical Company Information
6.3.2 Shanghai Benemae Pharmaceutical Description and Business Overview
6.3.3 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product Portfolio
6.3.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short-acting GLP-1RA Industry Chain Analysis
7.2 Short-acting GLP-1RA Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short-acting GLP-1RA Production Mode & Process Analysis
7.4 Short-acting GLP-1RA Sales and Marketing
7.4.1 Short-acting GLP-1RA Sales Channels
7.4.2 Short-acting GLP-1RA Distributors
7.5 Short-acting GLP-1RA Customer Analysis
8 Short-acting GLP-1RA Market Dynamics
8.1 Short-acting GLP-1RA Industry Trends
8.2 Short-acting GLP-1RA Market Drivers
8.3 Short-acting GLP-1RA Market Challenges
8.4 Short-acting GLP-1RA Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Sanofi
Shanghai Benemae Pharmaceutical
List of Tables
 Table 1. Global Short-acting GLP-1RA Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Short-acting GLP-1RA Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Short-acting GLP-1RA Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Short-acting GLP-1RA Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Short-acting GLP-1RA Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Short-acting GLP-1RA Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Short-acting GLP-1RA Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Short-acting GLP-1RA Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Short-acting GLP-1RA, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Short-acting GLP-1RA, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Short-acting GLP-1RA, Product Type & Application
 Table 12. Global Key Manufacturers of Short-acting GLP-1RA, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Short-acting GLP-1RA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short-acting GLP-1RA as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Short-acting GLP-1RA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Short-acting GLP-1RA Sales by Region (2020-2025) & (K Units)
 Table 18. Global Short-acting GLP-1RA Sales Market Share by Region (2020-2025)
 Table 19. Global Short-acting GLP-1RA Sales by Region (2026-2031) & (K Units)
 Table 20. Global Short-acting GLP-1RA Sales Market Share by Region (2026-2031)
 Table 21. Global Short-acting GLP-1RA Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Short-acting GLP-1RA Revenue Market Share by Region (2020-2025)
 Table 23. Global Short-acting GLP-1RA Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Short-acting GLP-1RA Revenue Market Share by Region (2026-2031)
 Table 25. North America Short-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Short-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 27. North America Short-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 28. North America Short-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Short-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Short-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Short-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Short-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Short-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Short-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Short-acting GLP-1RA Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Short-acting GLP-1RA Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Short-acting GLP-1RA Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Short-acting GLP-1RA Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Short-acting GLP-1RA Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Short-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Short-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Short-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Short-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Short-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Short-acting GLP-1RA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Short-acting GLP-1RA Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Short-acting GLP-1RA Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Short-acting GLP-1RA Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Short-acting GLP-1RA Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Short-acting GLP-1RA Sales (K Units) by Type (2020-2025)
 Table 51. Global Short-acting GLP-1RA Sales (K Units) by Type (2026-2031)
 Table 52. Global Short-acting GLP-1RA Sales Market Share by Type (2020-2025)
 Table 53. Global Short-acting GLP-1RA Sales Market Share by Type (2026-2031)
 Table 54. Global Short-acting GLP-1RA Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Short-acting GLP-1RA Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Short-acting GLP-1RA Revenue Market Share by Type (2020-2025)
 Table 57. Global Short-acting GLP-1RA Revenue Market Share by Type (2026-2031)
 Table 58. Global Short-acting GLP-1RA Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Short-acting GLP-1RA Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Short-acting GLP-1RA Sales (K Units) by Application (2020-2025)
 Table 61. Global Short-acting GLP-1RA Sales (K Units) by Application (2026-2031)
 Table 62. Global Short-acting GLP-1RA Sales Market Share by Application (2020-2025)
 Table 63. Global Short-acting GLP-1RA Sales Market Share by Application (2026-2031)
 Table 64. Global Short-acting GLP-1RA Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Short-acting GLP-1RA Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Short-acting GLP-1RA Revenue Market Share by Application (2020-2025)
 Table 67. Global Short-acting GLP-1RA Revenue Market Share by Application (2026-2031)
 Table 68. Global Short-acting GLP-1RA Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Short-acting GLP-1RA Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Short-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Short-acting GLP-1RA Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Short-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Short-acting GLP-1RA Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Shanghai Benemae Pharmaceutical Company Information
 Table 81. Shanghai Benemae Pharmaceutical Description and Business Overview
 Table 82. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product
 Table 84. Shanghai Benemae Pharmaceutical Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Short-acting GLP-1RA Distributors List
 Table 88. Short-acting GLP-1RA Customers List
 Table 89. Short-acting GLP-1RA Market Trends
 Table 90. Short-acting GLP-1RA Market Drivers
 Table 91. Short-acting GLP-1RA Market Challenges
 Table 92. Short-acting GLP-1RA Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Short-acting GLP-1RA
 Figure 2. Global Short-acting GLP-1RA Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Short-acting GLP-1RA Market Share by Type: 2024 & 2031
 Figure 4. Exenatide Product Picture
 Figure 5. Beinaglutide Product Picture
 Figure 6. Lixisenatide Product Picture
 Figure 7. Global Short-acting GLP-1RA Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Short-acting GLP-1RA Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Short-acting GLP-1RA Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Short-acting GLP-1RA Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Short-acting GLP-1RA Sales (2020-2031) & (K Units)
 Figure 15. Global Short-acting GLP-1RA Average Price (US$/Unit) & (2020-2031)
 Figure 16. Short-acting GLP-1RA Report Years Considered
 Figure 17. Short-acting GLP-1RA Sales Share by Manufacturers in 2024
 Figure 18. Global Short-acting GLP-1RA Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Short-acting GLP-1RA Players: Market Share by Revenue in Short-acting GLP-1RA in 2024
 Figure 20. Short-acting GLP-1RA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Short-acting GLP-1RA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Short-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 23. North America Short-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 24. United States Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Short-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 27. Europe Short-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Short-acting GLP-1RA Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Short-acting GLP-1RA Revenue Market Share by Region (2020-2031)
 Figure 35. China Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Short-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Short-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Short-acting GLP-1RA Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Short-acting GLP-1RA Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Short-acting GLP-1RA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Short-acting GLP-1RA by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Short-acting GLP-1RA by Type (2020-2031)
 Figure 55. Global Short-acting GLP-1RA Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Short-acting GLP-1RA by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Short-acting GLP-1RA by Application (2020-2031)
 Figure 58. Global Short-acting GLP-1RA Price (US$/Unit) by Application (2020-2031)
 Figure 59. Short-acting GLP-1RA Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Long acting GLP 1RA Market Research Report 2024
Global Ultra Long acting GLP 1RA Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global GLP 1 Drugs Market Research Report 2024
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral GLP 1 Agonist Market Research Report 2024
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GLP 1 Weight Loss Pill Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
GLP 1RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions